chr7-22493779-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001382447.1(STEAP1B):āc.142C>Gā(p.Gln48Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000044 in 1,613,526 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001382447.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
STEAP1B | NM_001382447.1 | c.142C>G | p.Gln48Glu | missense_variant | 3/5 | ENST00000678116.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
STEAP1B | ENST00000678116.1 | c.142C>G | p.Gln48Glu | missense_variant | 3/5 | NM_001382447.1 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 151788Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000319 AC: 8AN: 251060Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135676
GnomAD4 exome AF: 0.0000342 AC: 50AN: 1461620Hom.: 0 Cov.: 31 AF XY: 0.0000330 AC XY: 24AN XY: 727116
GnomAD4 genome AF: 0.000138 AC: 21AN: 151906Hom.: 0 Cov.: 31 AF XY: 0.000108 AC XY: 8AN XY: 74260
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 27, 2021 | The c.142C>G (p.Q48E) alteration is located in exon 3 (coding exon 2) of the STEAP1B gene. This alteration results from a C to G substitution at nucleotide position 142, causing the glutamine (Q) at amino acid position 48 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at